Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Chaingen Biopharma Ltd

Clinical trials sponsored by Chaingen Biopharma Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New Alzheimer's drug candidate takes first step in human safety trial Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New Alzheimer's drug candidate takes first step in human safety trial

Disease control Recruiting now

This study tests a single intravenous dose of an experimental drug called CGB3002 in healthy adults aged 18 to 55. The main goal is to see if the drug is safe and how the body processes it. This is a first step toward possibly developing a treatment for Alzheimer's disease.

Phase 1 • Sponsor: ChainGen Biopharma Ltd • Aim: Disease control

Last updated Jul 10, 2026 00:00 UTC